Henry Schein Overview

  • Year Founded
  • 1932

Year Founded

  • Status
  • Public

  • Employees
  • 25,000

Employees

  • Stock Symbol
  • HSIC

Stock Symbol

  • Investments
  • 104

  • Share Price
  • $83.52
  • (As of Friday Closing)

Henry Schein General Information

Description

Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.

Contact Information

Formerly Known As
Schein Henry
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 135 Duryea Road
  • Melville, NY 11747
  • United States
+1 (631)
Primary Industry
Distributors (Healthcare)
Stock Exchange
NAS
Corporate Office
  • 135 Duryea Road
  • Melville, NY 11747
  • United States
+1 (631)

Henry Schein Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Henry Schein Stock Performance

As of 20-Nov-2026, Henry Schein’s stock price is $83.52. Its current market cap is $9.2B with 111M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$83.52 $84.79 $68.70 - $92.18 $9.2B 111M 1.32M $3.69

Henry Schein Financials Summary

As of 30-Sep-2026, Henry Schein has a trailing 12-month revenue of $13.7B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 14,580,166 13,741,641 12,961,946 13,408,632
Revenue 13,734,000 13,184,000 12,673,000 12,339,000
EBITDA 1,013,000 931,000 888,000 834,000
Net Income 421,000 398,000 390,000 416,000
Total Assets 11,510,000 11,215,000 10,218,000 10,573,000
Total Debt 3,891,000 3,436,000 2,870,000 2,741,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Henry Schein Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Henry Schein‘s full profile, request access.

Request a free trial

Henry Schein Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and serv
Distributors (Healthcare)
Melville, NY
25,000 As of 2026

Zaragoza, Spain
 

Saint Paul, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Henry Schein Competitors (18)

One of Henry Schein’s 18 competitors is Proclinic, a Private Equity-Backed company based in Zaragoza, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Proclinic Private Equity-Backed Zaragoza, Spain
Patterson Companies Private Equity-Backed Saint Paul, MN
Benco Dental Corporate Backed or Acquired Pittston, PA
Steris Formerly PE-Backed Mentor, OH
DentalEZ Corporation Malvern, PA
You’re viewing 5 of 18 competitors. Get the full list »

Henry Schein Patents

Henry Schein Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12191385-B2 Semiconductor device having a current spreading region Active 11-Feb-2022
US-20230261104-A1 Semiconductor device having a current spreading region Active 11-Feb-2022
US-12127749-B1 Cement removal blade for osteotome Active 23-Mar-2021
US-12508035-B2 Scoring blade and method for bone cement removal from intramedullary canal Active 23-Mar-2021
US-20230355247-A1 Scoring blade and method for bone cement removal from intramedullary canal Active 23-Mar-2021 A61B17/1604
To view Henry Schein’s complete patent history, request access »

Henry Schein Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Henry Schein Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Henry Schein‘s full profile, request access.

Request a free trial

Henry Schein Investments & Acquisitions (104)

Henry Schein’s most recent deal was a Merger/Acquisition with R. Weinstein. The deal was made on 04-Mar-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
R. Weinstein 04-Mar-2025 Merger/Acquisition Distributors/Wholesale
Acentus 15-Jan-2025 Merger/Acquisition Other Healthcare Services
ABC Dental 15-Jul-2024 Merger/Acquisition Distributors/Wholesale
TriMed 01-Apr-2024 Merger/Acquisition Therapeutic Devices
Shield HealthCare (Distributors (Healthcare)) 02-Oct-2023 Merger/Acquisition Distributors (Healthcare)
You’re viewing 5 of 104 investments and acquisitions. Get the full list »

Henry Schein ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

11.04 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Distribution

Subindustry

of 42

Rank

Percentile

To view Henry Schein’s complete esg history, request access »

Henry Schein Exits (9)

Henry Schein’s most recent exit was on 02-Jun-2015 from Maravet. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Maravet 02-Jun-2015 Completed
Scil Animal Care Company 31-Mar-2015 Completed
Iwase Dental Supply 19-Oct-2014 Completed
SmartEquine 12-Aug-2014 Completed
  • 2 buyers
Sirona Dental Systems 03-Jun-2014 Merger/Acquisition Completed
You’re viewing 5 of 9 exits. Get the full list »

Henry Schein Affiliates

Subsidiaries (42)

Name Industry Location Year Founded
Large Practice Sales Dallas, TX 2017
Prism Medical Products Elkin, NC 2006
Medentis Medical Bad Neuenahr-Ahrweiler, Germany 2004
SIN Sistema de Implante Nacional Sao Paulo, Brazil 2003
Lighthouse 360 El Segundo, CA 2002
You’re viewing 5 of 42 affiliates. Get the full list.  »

Henry Schein FAQs

  • When was Henry Schein founded?

    Henry Schein was founded in 1932.

  • Where is Henry Schein headquartered?

    Henry Schein is headquartered in Melville, NY.

  • What is the size of Henry Schein?

    Henry Schein has 25,000 total employees.

  • What industry is Henry Schein in?

    Henry Schein’s primary industry is Distributors (Healthcare).

  • Is Henry Schein a private or public company?

    Henry Schein is a Public company.

  • What is Henry Schein’s stock symbol?

    The ticker symbol for Henry Schein is HSIC.

  • What is the current stock price of Henry Schein?

    As of 20-Nov-2026 the stock price of Henry Schein is $83.52.

  • What is the current market cap of Henry Schein?

    The current market capitalization of Henry Schein is $9.2B.

  • What is Henry Schein’s current revenue?

    The trailing twelve month revenue for Henry Schein is $13.7B.

  • Who are Henry Schein’s competitors?

    Proclinic, Patterson Companies, Benco Dental, Steris, and DentalEZ are some of the 18 competitors of Henry Schein.

  • What is Henry Schein’s annual earnings per share (EPS)?

    Henry Schein’s EPS for 12 months was $3.69.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process